Literature DB >> 15717165

The use of cyclosporine in a boy with a prior episode of posterior encephalopathy.

Chieko Nakahara1, Naoyuki Hasegawa, Isho Izumi, Katsuyosi Kanemoto, Nobuaki Iwasaki.   

Abstract

We report the case of a 12- year-old Japanese boy who was receiving cyclosporine (Cs A) for steroid-dependent nephrotic syndrome despite a prior episode of Cs A-associated posterior encephalopathy. At the third relapsing of nephrotic syndrome, Cs A was initiated. Eight days after the Cs A therapy, the boy was admitted to the University Hospital of Tsukuba because of generalized convulsion. Magnetic resonance imaging (MRI) showed hyperintense lesions involving the bilateral parieto-occipital region. Cs A was discontinued, and cyclophosphamide was started. The boy had a 6-month drug-free period after the cyclophosphamide treatment and then relapsed three more times in the following 5 months. As the prednisolone dosage could not be decreased to less than 2 mg/kg/48 h, the patient was re-challenged with Cs A 1 1/2 years later. Blood pressure and serum Cs A levels were measured frequently, an anti-hypertensive drug was given, and MRI was done four times to detect hyperintense lesions. He has been receiving Cs A for 9 months, and MRI has revealed no abnormalities. At the latest follow-up, dated 12 April 2004, he was in a remissive state of nephrotic syndrome. This is the first report of giving Cs A to a nephrotic child who had a previous history of Cs A-associated posterior encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717165     DOI: 10.1007/s00467-004-1752-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

Review 1.  Cyclosporine A neurotoxicity among bone marrow transplant recipients.

Authors:  A K Shah
Journal:  Clin Neuropharmacol       Date:  1999 Mar-Apr       Impact factor: 1.592

2.  Cyclosporine-associated central nervous system toxicity after renal transplantation.

Authors:  H Wilczek; O Ringden; G Tyden
Journal:  Transplantation       Date:  1985-01       Impact factor: 4.939

Review 3.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

4.  Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings.

Authors:  R Bakshi; V E Bates; L L Mechtler; P R Kinkel; W R Kinkel
Journal:  Epilepsia       Date:  1998-03       Impact factor: 5.864

5.  Posterior leukoencephalopathy syndrome may not be reversible.

Authors:  N L Antunes; T N Small; D George; F Boulad; E Lis
Journal:  Pediatr Neurol       Date:  1999-03       Impact factor: 3.372

6.  The blood-brain barrier and cerebral blood flow in acute hypertension.

Authors:  B B Johansson
Journal:  Acta Med Scand Suppl       Date:  1983

7.  Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging.

Authors:  P Mukherjee; R C McKinstry
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

Review 8.  Hepatotoxicity of transplant immunosuppressive agents.

Authors:  K V Kowdley; E B Keeffe
Journal:  Gastroenterol Clin North Am       Date:  1995-12       Impact factor: 3.806

9.  Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. Case report.

Authors:  E S Nussbaum; R E Maxwell; P B Bitterman; M I Hertz; W Bula; R E Latchaw
Journal:  J Neurosurg       Date:  1995-06       Impact factor: 5.115

10.  Influence of hepatic dysfunction on cyclosporine metabolism in the pig.

Authors:  G Mentha; C Schopfer; L Vadas; J Belenger; P Morel; F Criado; A Rohner
Journal:  Transpl Int       Date:  1992       Impact factor: 3.782

View more
  2 in total

Review 1.  Posterior reversible encephalopathy syndrome in children with kidney disease.

Authors:  Cristina Gavrilovici; Ingrith Miron; Luminiţa Voroneanu; Silvia Bădărau; Magdalena Stârcea
Journal:  Int Urol Nephrol       Date:  2017-08-23       Impact factor: 2.370

Review 2.  Posterior reversible encephalopathy syndrome in children with kidney diseases.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Robert H Mak; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.